55
In band
Moving averages
SMA 200$68.36+9.49%
Company profile
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates for ophthalmic conditions. The company is headquartered in Irvine, California.
SectorHealthcare
IndustryBiotechnology
Market cap$3.48B
P/E ratioNone
EPS$-1.06
Beta0.446
Dividend yield0.00%
52-week high$91.53
52-week low$53.89
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
VKTX
Viking Therapeutics Inc
RSI 48
ATAI
ATAI Life Sciences N.V.
RSI 62
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 54
AUPH
Aurinia Pharmaceuticals Inc
RSI 49
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 53
NVAX
Novavax Inc
RSI 45
RSI alerts for TARS
An email when TARS closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:59 PM EDT